Roldan Munoz, Sonia http://orcid.org/0000-0003-1471-9713
Postmus, Douwe http://orcid.org/0000-0002-9458-7038
de Vries, Sieta T. http://orcid.org/0000-0001-6090-2434
Gross-Martirosyan, Liana http://orcid.org/0000-0001-5522-1511
Bahri, Priya
Hillege, Hans http://orcid.org/0000-0001-7397-1148
Mol, Peter G. M. http://orcid.org/0000-0002-4262-3180
Funding for this research was provided by:
Horizon 2020 (754425)
Article History
Accepted: 14 November 2022
First Online: 15 February 2023
Declarations
:
: SRM, DP, STdV, HH and PM contributed to the formulation of the research question of this study and collected the data. SRM and DP analysed the data. All authors contributed to the interpretation of the data. SRM and SdV drafted the manuscript. All authors reviewed and edited the manuscript. All authors read and approved the final version of the manuscript.
: The study was conducted in the context of the PROMINENT project. This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement number 754425.
: Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans Hillege, and Peter G M Mol have no conflicts of interest relevant to the contents of this study.
: The Medical Ethics Review Board of the University Medical Center Groningen (METc UMCG) concluded that an ethical approval was not needed for this study (reference number M21.271770).
: The participants provided informed consent to participate in this survey study.
: The datasets generated or analysed during the current study are available from the corresponding author on reasonable request.
: The R scripts used for this study are available from the corresponding author on reasonable request.
: Participants were informed that the study results would be published in a scientific journal.
: The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the Dutch Medicines Evaluation Board, the European Medicines Agency, or any of their committees.